Trinity, a leading global life sciences consulting firm, today announced it will be a Program Partner for the “Gene Therapy For Rare Disorders” conference taking place on March 26-28 in Boston. Trinity’s Krista Perry will be presenting at the conference to highlight Trinity’s continued involvement supporting companies commercializing products for rare diseases, including our significant experience with gene and cell therapies. With Trinity as a key sponsor, this event brings together 450+ industry leaders and experts from innovative biotechs, large…
Read Now
Trinity, a leading global life sciences consulting firm, announced that it will be presenting two posters at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting on March 25-28 in San Diego. This event brings together national leaders to discuss the latest developments on evidence- and value-based strategies to increase patient access to affordable medicine.
Trinity’s AMCP presentations include: 1) A medical chart review quantifying the “Unmet Needs in the Diagnosis and Treatment of Women With Hypoactive Sexual Desire Disorder”…
Read Now
E. Norriton, Penn., Jan. 8, 2019
TGaS® Advisors, a division of Trinity, has announced four new additions to the benchmarking and advisory services firm. Dmitry Kublanov is vice president, Pricing, Contracting & Analytics, and Jerry Luciano is vice president, Omnichannel Marketing (formerly Digital and Multichannel Marketing). Learning & Development added Steve Regan as executive director and Kristin Scott as director.
Kublanov comes to TGaS with more than 20 years in Managed Markets pricing and reimbursement, contract management system integration, deal analytics…
Read Now
Therapies for breast cancer, multiple myeloma, and HIV ranked the highest across audit of commercial performance, therapeutic value, and R&D complexity.
WALTHAM, Mass. – December 17, 2018 — Trinity, a leading global life science consulting firm, today announced the findings of its third annual Trinity Drug Index which assessed 57 novel drugs approved by the FDA in 2015. The index ranks drug performance against three categories: commercial performance, therapeutic value and R&D complexity, assigning each drug a score in those…
Read Now
Leading global life sciences consulting firm Trinity has been named to Consulting Magazine’s 2018 lists of “Best Small Firms to Work For” as well as the magazine’s list of “Fastest Growing Firms” for the third consecutive year.
Consulting Magazine’s annual ranking of the industry’s “Best Firms to Work For” is based on employee survey responses regarding six areas of employee satisfaction including culture, career development, work/life balance, client engagement, compensation and benefits, and firm leadership. Consulting Magazine’s list of “Fastest…
Read Now
Experts from Trinity have published a bylined article in In Vivo. The article, titled, “You May Be Making These Drug Forecasting Mistakes,” breaks down the most common missteps in forecasting and highlights how to design and use the best models for the most accurate outcomes. In the article, Alex Chiang, Principal, and Adrian Watson, Senior Manager, Modeling and Analytics, discuss the top 10 most common drug forecasting errors, which fall into three broad categories: model design issues, model maintenance issues,…
Read Now
Waltham, MA—Global life sciences consulting firm Trinity today announced it will present the panel discussion, “Tissue-Agnostic Cancer Drug Development: An Emerging Paradigm Shift?” along with Pfizer and the Healthcare Businesswomen’s Association (HBA). The event, featuring perspectives from clinical, commercial, regulatory and market access experts, will take place at Pfizer’s headquarters in New York City on October 23, 2018 from 5:30-8 pm.
Cancer treatment has made significant strides toward the promise of personalized medicine in recent years. With Keytruda’s tissue-agnostic MSI-H/dMMR…
Read Now
Trinity issued a paper on asset valuation that explores the common methodologies for the valuation of pharma and biotech assets and highlights key considerations for capturing asset-specific nuances and accurately reflecting value.…
Read Now
Click here to visit TGaS.com
Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry
Waltham, MA—Global life sciences consulting firm Trinity today announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity’s overarching growth strategy and builds upon previous successes and momentum including a strengthened…
Read Now
Boston, August 20, 2018 – Leading global life sciences consulting firm Trinity today announced that it has welcomed new Principal, Christian Frois, PhD, to the firm as well as seven other individuals to its leadership team. Trinity also welcomes new full-time hires, totaling 40 new employees company-wide this year to date.
Frois specializes in the development and evaluation of innovative commercial and evidence strategies for biopharmaceutical and medical device companies, and is a recognized expert on pricing, contracting and market…
Read Now
